Skip to main content

David Fox

ID:LEX-AR-GW0RFHNF

/

Unclaimed

/

Organization: Hogan Lovells

Europe approves its first mAb biosimilar & FDA is handling 17 biosimilar INDs

Biosimilars Law Blog · October 7, 2013

If you missed the Maximizing Patent Life Cycles panel discussion, you may want to read this

Biosimilars Law Blog · November 7, 2012

FDA Denies 5-Year Exclusivity to “Stable Esters” and Confirms Structure-Based Approach to Exclusivity

Focus on Regulation · October 1, 2012

Biosimilars Marching Forward as Planned

Biosimilars Law Blog · June 29, 2012

Breaking decisions from the Supreme Court: Term in review

Biosimilars Law Blog · June 21, 2012